We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
-$296M
(-9.9%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
1.65%
Top 10 Holdings %
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$26.9M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$24.9M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$19.8M |
| 4 |
Morgan Stanley
MS
|
+$18.5M |
| 5 |
Kraft Heinz
KHC
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$22.3M |
| 2 |
Amgen
AMGN
|
+$21.9M |
| 3 |
Alibaba
BABA
|
+$18.9M |
| 4 |
SLB Ltd
SLB
|
+$18M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.76% |
| 2 | Technology | 13.33% |
| 3 | Consumer Discretionary | 12.45% |
| 4 | Industrials | 11.02% |
| 5 | Financials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Neogen
NEOG
$2.05B
| $236K | 0.01% |
13,992
-3,477
| -20% | -$68.4K |
|
|
WMGI
1127
DELISTED
Wright Medical Group Inc
WMGI
| $236K | 0.01% |
+11,254
| New | +$281K |
|
1128
Arthur J. Gallagher & Co
AJG
$69.1B
| $234K | 0.01% |
+5,682
| New | +$258K |
|
1129
Coeur Mining
CDE
$15.1B
| $234K | 0.01% |
83,228
-195,538
| -70% | -$711K |
|
1130
Intrepid Potash
IPI
$476M
| $234K | 0.01% |
4,241
-2,660
| -39% | -$221K |
|
1131
Amphastar Pharmaceuticals
AMPH
$907M
| $230K | 0.01% |
+19,720
| New | +$296K |
|
1132
STAG Industrial
STAG
$7.44B
| $230K | 0.01% |
+12,664
| New | +$239K |
|
|
HSTO
1133
DELISTED
Histogen Inc. Common Stock
HSTO
| $230K | 0.01% |
259
-126
| -33% | -$115K |
|
|
JBTM
1134
JBT Marel
JBTM
$7.35B
| $228K | 0.01% |
+5,968
| New | +$216K |
|
|
ASEI
1135
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $228K | 0.01% |
6,436
-3,415
| -35% | -$139K |
|
1136
Medallion Financial
MFIN
$230M
| $226K | 0.01% |
29,862
+4,845
| +19% | +$38.5K |
|
|
SLCA
1137
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $226K | 0.01% |
+16,061
| New | +$342K |
|
|
CHMT
1138
DELISTED
Chemtura Corporation
CHMT
| $225K | 0.01% |
+7,872
| New | +$215K |
|
1139
Dorian LPG
LPG
$1.96B
| $224K | 0.01% |
+21,778
| New | +$300K |
|
1140
Agree Realty
ADC
$9.66B
| $223K | 0.01% |
7,488
-7,215
| -49% | -$215K |
|
1141
Vitamin Cottage Natural Grocers
NGVC
$760M
| $222K | 0.01% |
9,822
-4,336
| -31% | -$104K |
|
1142
NorthWestern Energy
NWE
$4.34B
| $220K | 0.01% |
4,094
-10,951
| -73% | -$571K |
|
|
WPX
1143
DELISTED
WPX Energy, Inc.
WPX
| $219K | 0.01% |
33,210
-478,826
| -94% | -$4.01M |
|
|
CIR
1144
DELISTED
CIRCOR International, Inc
CIR
| $217K | 0.01% |
+5,412
| New | +$251K |
|
|
USAK
1145
DELISTED
USA Truck Inc
USAK
| $217K | 0.01% |
+12,595
| New | +$251K |
|
|
RLD
1146
DELISTED
REALD INC COM STK
RLD
| $216K | 0.01% |
+22,511
| New | +$244K |
|
1147
M/I Homes
MHO
$3.95B
| $214K | 0.01% |
+9,077
| New | +$225K |
|
|
TTOO
1148
DELISTED
T2 Biosystems, Inc
TTOO
| $214K | 0.01% |
5
+2
| +67% | +$133K |
|
|
ARC
1149
DELISTED
ARC Document Solutions, Inc.
ARC
| $214K | 0.01% |
36,018
-35,048
| -49% | -$237K |
|
1150
FIVE9
FIVN
$2.08B
| $213K | 0.01% |
57,642
-6,684
| -10% | -$30.2K |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
- A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
- A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
- A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
- A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
- A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
- A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
- A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.
Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.